The world's largest seed company, Monsanto Company (
), is at the very core of the genetically modified food debate that
divides millions over the pending world food supply. Monsanto's
products and technologies are central to the ongoing safety and
ethics debate of genetically engineered and genetically modified
foods, and the "terminator" seed. Monsanto's use of biotechnology
and seed patents is often critiqued in the media and by various
organic foods and consumer associations.
Monsanto Company dominates an estimated 40% of the conventional
seed market in the U.S. and 20% worldwide, causing GMO concern
around the globe. A worldwide protest was launched against Monsanto
Company in May 2013 when 71 U.S. senators voted against an
amendment that would have guaranteed states the right to enact
mandatory GMO labeling laws. About that protest, NaturalNews
reported: "Two million people in over 50 countries expressed
outrage over Monsanto's desire to own the food supply through
genetically-altered (and patented) seeds that threaten all life on
this planet." In mid-August, thousands of Chileans protested a bill
dubbed the "Monsanto law" that would let multinationals patent GMO
seeds, according to GM Watch.
Incorporated in 2000, Monsanto Company is a multinational
agricultural biotechnology corporation headquartered in St. Louis,
Mo. The company is up 11% over 12 months, with a market cap of
$51.78 billion; its shares were traded at around $97.86 with a P/E
ratio of 21.00 and a P/B of 3.80.
Monsanto is a provider of agricultural products including seeds,
biotechnology trait products, and herbicides. Through its Seeds and
Genomics segment, Monsanto produces seed brands, including DEKALB,
Asgrow, Deltapine, Seminis and De Ruiter, and develops
biotechnology traits that control insects and weeds. It also
provides other seed companies with genetic material and
biotechnology traits for its seed brands. Monsanto produces
directly or contract with third-party growers around the world for
corn seed, soybean seed, vegetable seeds, cotton seed, canola seed
and other seeds.
On June 26, 2013, Monsanto Company reported fiscal year 2013
results: For the first nine months, net sales increased $1.3
billion over the prior year period to approximately $12.7 billion.
Net sales for the quarter were $4.2 billion. Operating expenses
were up $11 million in the third quarter compared to the same
period in the prior year. Quarterly research and development
expenses were up 5% to $392 million compared to the prior year
period. The company's third quarter earnings per share (
) was $1.66 on an ongoing and $1.68 on an as-reported basis. EPS
for the first nine months of fiscal year 2013 was $5.01 on an
ongoing basis and $5.05 on an as-reported basis.
Tracking historical share price, revenue and net
Monsanto Company's dividend yield over 13 years:
Guru Action in Second Quarter
As of June 30, 2013, 22 billionaires hold MON shares. The top
billionaire stakeholder of MON is
with 12,225,167 shares or 2.28% of shares outstanding, followed by
with 6,309,475 shares or 1.18 shares outstanding; Steve Mandel is
third, with 6,207,263 shares or 1.16% of shares outstanding.
Five gurus bought or added MON in the second quarter, while seven
reduced their MON holding and four gurus sold out as of June 30,
As of June 30, 2013, Andreas Halvorsen increased his position by
747.42%, buying 3,700,588 shares at an average price of $104.72,
for a loss of 6.9%.
His highest gain was 40% in the third quarter of 2011 when he
bought 843,700 shares at an average price of $69.66 per share.
As of June 30, 2013, John Burbank bought a new holding after
selling out in the first quarter of 2013. He bought 102,389 shares
at an average price of $104.72, for a loss of 7.3%.
His highest gain was 75.4% in the third quarter of 2010 when he
bought 110,000 shares at an average price of $55.38 per share.
As of June 30, 2013, Pioneer Investments increased its position by
209.66%, buying 652,995 shares at an average price of $104.72, for
a loss of 7.3%.
The firm has averaged a gain was 12% on 2,142,545 shares bought at
an average price of $87.05 per share. On shares sold, the firm
averaged a gain of 32% on 1,178,103 shares sold at an average price
of $73.68 per share.
As of June 30, 2013, Steven Cohen decreased his position by 67.24%,
selling 306,297 shares at an average price of $104.72, for a loss
He has averaged a gain was 18% on 2,364,550 shares bought at an
average price of $82.61 per share. On shares sold, he averaged a
gain of 10% on 2,215,335 shares sold at an average price of $88.19
As of June 30, 2013, four billionaires sold out their MON
positions: Meridian Funds, John Hussman, Joel Greenblatt, and Tom
Russo each took a loss of 7.3% on the holding.
Study more of the Monsanto Company trades here.
Use the GuruFocus Value Screen to find 52-Week Lows and discover
potentially deep value stocks held by billionaire Guru investors.
GuruFocus Real Time Picks reports the stock purchases and sales
that Gurus have made within the prior 2 weeks. The report time lag
can be as short as 2 days after the date of the transaction. This
feature is for Premium Members only.
If you are not a Premium Member, we invite you for
7-day Free Trial
About GuruFocus: GuruFocus.com tracks the stocks picks and
portfolio holdings of the world's best investors. This value
investing site offers stock screeners and valuation tools. And
publishes daily articles tracking the latest moves of the world's
best investors. GuruFocus also provides promising stock ideas in 3
monthly newsletters sent to